KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Merck (MRK) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $2.32.

  • Merck's EPS (Weighted Average and Diluted) rose 8709.68% to $2.32 in Q3 2025 from the same period last year, while for Sep 2025 it was $7.57, marking a year-over-year increase of 5870.02%. This contributed to the annual value of $6.74 for FY2024, which is 471428.57% up from last year.
  • According to the latest figures from Q3 2025, Merck's EPS (Weighted Average and Diluted) is $2.32, which was up 8709.68% from $1.76 recorded in Q2 2025.
  • In the past 5 years, Merck's EPS (Weighted Average and Diluted) ranged from a high of $2.32 in Q3 2025 and a low of -$2.35 during Q2 2023
  • Over the past 5 years, Merck's median EPS (Weighted Average and Diluted) value was $1.48 (recorded in 2024), while the average stood at $1.25.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first crashed by 25161.29% in 2023, then skyrocketed by 40833.33% in 2024.
  • Over the past 5 years, Merck's EPS (Weighted Average and Diluted) (Quarter) stood at $1.48 in 2021, then fell by 20.27% to $1.18 in 2022, then crashed by 140.68% to -$0.48 in 2023, then skyrocketed by 408.33% to $1.48 in 2024, then skyrocketed by 56.76% to $2.32 in 2025.
  • Its last three reported values are $2.32 in Q3 2025, $1.76 for Q2 2025, and $2.01 during Q1 2025.